Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 11, 2026

Mapping Genome-wide Accessible Chromatin in Primary Human T Lymphocytes by ATAC-Seq
09:08

Mapping Genome-wide Accessible Chromatin in Primary Human T Lymphocytes by ATAC-Seq

Published on: November 13, 2017

ATAC trial update

Lucia Del Mastro, Marco Venturini

    Lancet (London, England)
    |April 7, 2005
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    ATAC-seq Assay with Low Mitochondrial DNA Contamination from Primary Human CD4+ T Lymphocytes
    08:36

    ATAC-seq Assay with Low Mitochondrial DNA Contamination from Primary Human CD4+ T Lymphocytes

    Published on: March 22, 2019

    ATAC-Seq Optimization for Cancer Epigenetics Research
    07:13

    ATAC-Seq Optimization for Cancer Epigenetics Research

    Published on: June 30, 2022

    Related Experiment Videos

    Last Updated: Jul 11, 2026

    Mapping Genome-wide Accessible Chromatin in Primary Human T Lymphocytes by ATAC-Seq
    09:08

    Mapping Genome-wide Accessible Chromatin in Primary Human T Lymphocytes by ATAC-Seq

    Published on: November 13, 2017

    ATAC-seq Assay with Low Mitochondrial DNA Contamination from Primary Human CD4+ T Lymphocytes
    08:36

    ATAC-seq Assay with Low Mitochondrial DNA Contamination from Primary Human CD4+ T Lymphocytes

    Published on: March 22, 2019

    ATAC-Seq Optimization for Cancer Epigenetics Research
    07:13

    ATAC-Seq Optimization for Cancer Epigenetics Research

    Published on: June 30, 2022

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Dose-dense adjuvant chemotherapy in HER2-low breast cancer: An exploratory analysis of the GIM2 trial.

    Breast (Edinburgh, Scotland)·2026
    Same author

    QIAstat-Dx Syndromic Molecular Testing Versus Conventional Diagnostics in Acute Gastroenteritis: Impact on Pathogen Detection and Laboratory Workflow.

    Microorganisms·2026
    Same author

    Strengths and pitfalls of NNT and NNH in early breast cancer escalation trials.

    Breast (Edinburgh, Scotland)·2026
    Same author

    Efficacy of alectinib for ALK-positive NSCLC according to tumor burden and body mass index: A pooled analysis of the randomized phase III trials ALEX and J-ALEX.

    European journal of cancer (Oxford, England : 1990)·2026
    Same author

    Immunotherapeutic strategies in HPV-positive and HPV-negative recurrent/metastatic oropharyngeal squamous cell carcinoma: From PD-1 blockade to EGFR-directed bispecifics and therapeutic HPV vaccines.

    Critical reviews in oncology/hematology·2026
    Same author

    Integrating PIK3CA Testing into Clinical Practice for Advanced HR+/HER2- Breast Cancer: An Expert Consensus.

    Breast (Edinburgh, Scotland)·2026